Search results for "Dopamine"

showing 10 items of 660 documents

Electrocatalysis of neurotransmitter catecholamines by 2,4,6-triphenylpyrylium ion immobilized inside zeolite Y supercages

1999

2,4,6-Triphenylpyrylium ions entrapped inside the supercages of Y zeolite exert a remarkable catalytic effect toward the electrochemical oxidation of dopamine and norepinephrine (neurotrasmitter catecholamines) in neutral aqueous media. Domenech Carbo, Antonio, Antonio.Domenech@uv.es

endocrine system diseasesUNESCO::QUÍMICAInorganic chemistryElectrocatalysis ; Trphenylpyrydium ; Y zeolite ; Neurotransmitter ; Catalytic effectNanotechnologyElectrochemistryElectrocatalyst:QUÍMICA [UNESCO]CatalysisCatalytic effectIonNorepinephrine (medication)chemistry.chemical_compoundDopamineCatalytic effectMaterials ChemistrymedicineTrphenylpyrydiumNeurotransmitterNeurotransmitterZeoliteUNESCO::QUÍMICA::Química analíticaY zeoliteMetals and AlloysGeneral ChemistrySurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryCeramics and Composites:QUÍMICA::Química analítica [UNESCO]Electrocatalysismedicine.drug
researchProduct

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

2008

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/ LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). METHODS: A search of the literature was carried out using PubMed and the authors’ files. RESULTS: In rodents and humans, the expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases during ovarian stimulation. With the administration of hCG, the expression of each rises to a maximum. Expression of VEGF/VEGFR-2 mRNAs correlates with enhanced VP, with both peaking 48 h following an injection of hCG. Imm…

endocrine systemmedicine.medical_specialtyCabergolineIndolesOvarian hyperstimulation syndromeVascular permeabilityBiologyChorionic GonadotropinDopamine agonistCapillary PermeabilityOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineCabergolinemedicineAnimalsHumansPyrrolesErgolinesPhosphorylationCells CulturedClinical Trials as TopicEstradiolVascular Endothelial Growth FactorsObstetrics and GynecologyEstrogensKinase insert domain receptormedicine.diseaseRatsVascular endothelial growth factorActin CytoskeletonVascular endothelial growth factor Amedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsReproductive Control AgentsFemaleCorpus luteumSignal Transductionmedicine.drugHuman Reproduction Update
researchProduct

In vitro synthesis of dopamine and noradrenaline in the isolated rat pineal gland: day-night variations and effects of electrical stimulation.

1989

: Isolated rat pineal glands were incubated in vitro in a medium containing [I4C]dopamine or [14C]tyrosine, and the tissue contents of l4C-labelled and total dopamine and noradrenaline were determined by HPLC followed by electrochemical detection and scintillation spectrometry. During incubation with [l4C]dopamine, the labelled amine accumulated in pineal glands and was partially converted into [l4C]noradrenaline. Nomifensine, a neuronal amine uptake blocker, largely inhibited the accumulation of [l4C]dopamine and the formation of [14C]noradrenaline. These experiments demonstrated dopamine β-hydroxylase activity in the sympathetic nerves of the pineal gland. During incubation with [14C]tyro…

endocrine systemmedicine.medical_specialtyDopamineEndogenyStimulationBiologyIn Vitro TechniquesBiochemistryPineal GlandCellular and Molecular NeuroscienceNorepinephrinePineal glandNorepinephrineDopamineInternal medicinemedicineAnimalsTyrosineTyrosine hydroxylaseRats Inbred StrainsElectric StimulationCircadian RhythmRatsNomifensinemedicine.anatomical_structureEndocrinologyTyrosineFemalemedicine.drugJournal of neurochemistry
researchProduct

Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.

1992

We assessed the 24-h behavior of circulating TSH and the dopaminergic control on TSH release in a postmenopausal woman, who had elevated levels of serum thyroid hormones and an inappropriately high concentration of serum TSH, indicating pituitary resistance to thyroid hormone action. The patient was found to have a daily profile of serum TSH similar to that of normal subjects, except for the persistently elevated 24 h levels, suggesting that alterations in thyroid hormone negative feedback control did not affect substantially circadian TSH rhythm. The acute administration of a dopamine antagonist drug (metoclopramide) resulted in a markedly elevated peak of serum TSH, similar both in the mo…

endocrine systemmedicine.medical_specialtyThyroid Hormonesendocrine system diseasesEndocrinology Diabetes and MetabolismDrug ResistanceThyrotropinThyroid Function TestsThyroid function testsHyperthyroidismEndocrinologyTRH stimulation testInternal medicinemedicineHumansCircadian rhythmmedicine.diagnostic_testbusiness.industryThyroidDopaminergicDopamine antagonistMiddle AgedBromocriptineCircadian Rhythmmedicine.anatomical_structureEndocrinologyPituitary GlandFemaleMenopausebusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugJournal of endocrinological investigation
researchProduct

A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiog…

2021

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mouse models however, D2-ags have been shown to cause a shift of the immature vessels towards a more mature phenotype but not a significant reduction in the amount of vascularization and size of lesions. These has raised concerns on whether the antiangiogenic effects of these compounds confer a therapeutic value for endometriosis. In the belief that antiangiogenic effects of D2-ags in endometriosis were masked due to non-optimal timing of pharmacological inte…

endometriosis0301 basic medicineAgonistAngiogenesismedicine.drug_classEndometriosisdopamine agonistMedicine (miscellaneous)Dopamine agonistArticleGeneral Biochemistry Genetics and Molecular BiologyLesion03 medical and health sciencesheterologous mouse model0302 clinical medicineIn vivoCabergolinemedicinelcsh:QH301-705.5030219 obstetrics & reproductive medicinebusiness.industryantiangiogenicmedicine.disease030104 developmental biologylcsh:Biology (General)anti-VEGFDopamine receptorCancer researchmedicine.symptombusinessmedicine.drugBiomedicines
researchProduct

Evaluación estandarizada del potencial antiangiógénico del agonista dopaminérgico en el tratamiento de la endometriosis

2018

La endometriosis es una enfermedad crónica, de elevada prevalencia y etiopatogenia no claramente establecida, para la que no se dispone, actualmente, de un tratamiento seguro y eficaz a largo plazo. El establecimiento de la angiogénesis como uno de los requisitos fundamentales en la implantación y desarrollo de la enfermedad ha llevado a considerar los fármacos antiangiogénicos como una potencial diana terapéutica. Estos compuestos han demostrado, en modelos animales, reducir el tamaño de las lesiones endometriales; sin embargo, el uso de estos compuestos en humanos se ve limitado por el intolerable perfil de efectos secundarios que presenta. Los agonistas dopaminérgicos (fármacos con un pe…

endometriosisantiangiogénicos y endometriosisangiogénesis y agonistas dopaminérgicosangiogénesis y endometriosisagonistas dopaminergicosUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Ginecologíatratamiento endometriosis:CIENCIAS MÉDICAS ::Ciencias clínicas::Ginecología [UNESCO]cabergolina
researchProduct

DEFECTS IN DOPAMINERGIC PATHWAY AFFECT CONTRACTILITY OF COLON FROM HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HPRT) KNOCKOUT MICE.

2010

Lesch-Nyhan disease is an X-linked neurobehavioral and metabolic disorder caused by lack of hypoxanthine phosphoribosyltransferase (HPRT), a housekeeping enzyme responsible for recycling purines. The mechanisms underlying the neuropathology are not well understood, but the main neurochemical defect, in central nervous system, is linked to a dysfunction of dopaminergic pathway. In the enteric nervous system the dopaminergic nerves are a subset neurons of regulating gut motility, thus we investigated possible changes in colonic motility of HPRT ¯mice related to the dopaminergic control. We evaluated, in vitro, the mechanical activity of circular muscle strips from wild type and HPRT – mouse c…

hprt dopamine gastrointestinal tract
researchProduct

Bidirectional cell-matrix interaction dictates neuronal network formation in a brain-mimetic 3D scaffold

2022

Human pluripotent stem cells (hPSC) derived neurons are emerging as a powerful tool for studying neurobiology, disease pathology, and modeling. Due to the lack of platforms available for housing and growing hPSC-derived neurons, a pressing need exists to tailor a brain-mimetic 3D scaffold that recapitulates tissue composition and favourably regulates neuronal network formation. Despite the progress in engineering biomimetic scaffolds, an ideal brain-mimetic scaffold is still elusive. We bioengineered a physiologically relevant 3D scaffold by integrating brain-like extracellular matrix (ECM) components and chemical cues. Culturing hPSCs-neurons in hyaluronic acid (HA) gels and HA-chondroitin…

hyaluronaaniindusoidut monikykyiset kantasolutInduced Pluripotent Stem CellsBiomedical Engineeringkudosviljelybiomimeettiset materiaalitBiochemistryBiomaterialsbrain-mimetic hydrogel scaffoldBiomimeticshyaluronic acidAnimalsHumanshuman pluripotent stem cellsMolecular Biologychondroitin sulfateNeuronsdopamiini318 Medical biotechnologyTissue ScaffoldsBrainhermoverkot (biologia)General MedicineExtracellular Matrixhermosolut3111 Biomedicineneuronal networkdopamineBiotechnology
researchProduct

DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator

2014

in vivo testingDopaminergic modulatormolecular modelingSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSettore BIO/14 - FarmacologiaSettore CHIM/08 - Chimica Farmaceuticaaminoacid conjiugate
researchProduct

Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

2009

Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All ri…

inorganic chemicalsHalogenationStereochemistryChemical synthesisReceptors DopamineStructure-Activity Relationshipchemistry.chemical_compoundStructure–activity relationshipsDopamineTetrahydroisoquinolinesBiogenic amineDrug DiscoverymedicineAnimalsStructure–activity relationshipRats WistarNeurotransmitterDopamine receptorsSTRUCTURE-ACTIVITY RELATIONSHIPSPharmacologychemistry.chemical_classification1-Halogenated benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolinesDopamine uptakReceptors Dopamine D2Receptors Dopamine D1Otras Ciencias QuímicasOrganic ChemistryDopaminergicCiencias QuímicasGeneral MedicineBinding1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolinesRatschemistryDopamine receptorDOPAMINE UPTAKECatecholamineFemaleCIENCIAS NATURALES Y EXACTASProtein Bindingmedicine.drug
researchProduct